The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers (Q46711334)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2005

Language	Label	Description	Also known as
English	The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers	scientific article published in October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Nenad Sarapa

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

Poe-Hirr Hsyu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

Graham Lappin

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

Ronald Colin Garner

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

45

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

1198-1205

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

Radiocarbon dating using electrostatic accelerators: negative ions provide the key.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometry

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a far

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280051

21 January 2018

Identifiers

10.1177/0091270005280051

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172185

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46711334&oldid=2127714442"